Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005776 · ClinicalTrials.gov registry record · Phase 3
Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
A Phase 3 study, sponsored by NICHD Neonatal Research Network.
- Terminated
- Registry status
- Phase 3
- Development phase
- 235
- Enrollment target
NCT00005776 is a Phase 3 study that was terminated before completion, run by NICHD Neonatal Research Network. The registered enrollment target is 235 participants.
The verdict
NCT00005776, a Phase 3 study, was terminated before completion, sponsored by NICHD Neonatal Research Network.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 235 participants
- Enrollment target
Study Summary
Respiratory failure in term newborns is associated with increased rates of death and long-term neurodevelopmental problems. This large international multicenter trial randomized newborns who had failed to respond to intensive care, including high levels of ventilator support, to receive either inhaled nitric oxide (iNO) or 100 percent oxygen to test whether iNO would decrease their risk of dying or requiring temporary lung bypass. Infants were followed during their initial hospitalization; their outcome was assessed at 18 to 24 mos of age.
Interventions
- DRUG Placebo
- DRUG Inhaled nitric oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 1995-10 |
| Est. Completion | 1998-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005776
The ClinicalTrials.gov registry entry for NCT00005776 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00005776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005776 about?
NCT00005776 is a clinical study titled "Inhaled Nitric Oxide Study for Respiratory Failure in Newborns". Respiratory failure in term newborns is associated with increased rates of death and long-term neurodevelopmental problems. This large international multicenter trial randomized newborns who had failed to respond to intensive care, including high levels of ventilator support, to receive either inhal...
What is the current status of trial NCT00005776?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 235 participants. The study started on 1995-10. Estimated completion is 1998-05.
What interventions are being tested in trial NCT00005776?
The interventions under investigation include: Placebo (DRUG), Inhaled nitric oxide (DRUG).
Who is sponsoring clinical trial NCT00005776?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.